Asiri Surgical Hospital PLC (COSE:AMSL.N0000)
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Asiri Surgical Hospital Ratios and Metrics
Market cap in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,081 | 8,138 | 6,077 | 6,130 | 6,606 | 7,927 | |
Market Cap Growth | -2.90% | 33.91% | -0.86% | -7.20% | -16.67% | 8.70% |
Enterprise Value | 9,748 | 11,013 | 9,105 | 9,517 | 10,696 | 10,401 |
Last Close Price | 13.40 | 15.40 | 11.50 | 11.29 | 12.17 | 13.72 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.35 | 10.00 | 22.88 | 194.30 | 11.90 | 6.69 |
PS Ratio | 0.90 | 1.05 | 0.85 | 0.93 | 1.17 | 1.36 |
PB Ratio | 0.89 | 1.00 | 0.88 | 0.94 | 1.07 | 1.50 |
P/TBV Ratio | 0.96 | 1.07 | 0.94 | 0.99 | 1.10 | 1.54 |
P/FCF Ratio | 78.93 | - | - | 61.93 | 26.60 | 9.18 |
P/OCF Ratio | 9.50 | 19.13 | - | 24.94 | 11.58 | 7.02 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.24 | 1.43 | 1.27 | 1.44 | 1.90 | 1.78 |
EV/EBITDA Ratio | 6.11 | 6.78 | 8.97 | 11.26 | 8.24 | 5.99 |
EV/EBIT Ratio | 8.22 | 9.03 | 14.57 | 21.93 | 11.20 | 7.34 |
EV/FCF Ratio | 108.66 | - | - | 96.15 | 43.07 | 12.05 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.33 | 0.34 | 0.42 | 0.50 | 0.67 | 0.65 |
Debt / EBITDA Ratio | 1.64 | 1.67 | 2.86 | 3.86 | 3.19 | 1.98 |
Debt / FCF Ratio | 29.10 | - | - | 33.00 | 16.67 | 3.98 |
Net Debt / Equity Ratio | 0.26 | 0.26 | 0.37 | 0.43 | 0.62 | 0.59 |
Net Debt / EBITDA Ratio | 1.29 | 1.28 | 2.53 | 3.32 | 2.98 | 1.80 |
Net Debt / FCF Ratio | 23.00 | -21.77 | -5.91 | 28.34 | 15.58 | 3.62 |
Asset Turnover | 0.48 | 0.50 | 0.52 | 0.50 | 0.47 | 0.61 |
Inventory Turnover | 25.98 | 24.49 | 23.82 | 16.40 | 11.89 | 13.32 |
Quick Ratio | 0.35 | 0.53 | 0.46 | 0.29 | 0.30 | 0.36 |
Current Ratio | 1.29 | 1.09 | 1.03 | 1.32 | 1.27 | 1.19 |
Return on Equity (ROE) | 12.59% | 12.52% | 5.58% | 1.94% | 11.15% | 25.06% |
Return on Assets (ROA) | 4.52% | 4.92% | 2.84% | 2.06% | 5.00% | 9.20% |
Return on Invested Capital (ROIC) | 7.15% | 7.21% | 2.79% | 0.86% | 5.25% | 15.46% |
Return on Capital Employed (ROCE) | 12.20% | 12.20% | 7.00% | 4.90% | 10.80% | 19.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 11.97% | 10.00% | 4.37% | 0.52% | 8.40% | 14.95% |
FCF Yield | 1.27% | -1.17% | -7.16% | 1.62% | 3.76% | 10.89% |
Dividend Yield | - | - | 2.61% | - | - | 15.31% |
Payout Ratio | - | 0.01% | 19.12% | 0.08% | 84.48% | 53.53% |
Total Shareholder Return | 0.32% | - | 2.61% | - | - | 15.31% |